| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 683920 | Null | 0.00126165886744893 | 0.46377679 |
| NSC 6883 | Null | 0.00126165886744893 | 0.50864751 |
| NSC 690035 | Null | 0.00126165886744893 | 0.40786932 |
| NSC 708424 | Null | 0.00126165886744893 | 0.55867486 |
| NSC 710391 | Null | 0.00126165886744893 | 0.46464679 |
| NSC 727049 | 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline | 0.00126165886744893 | 0.70879053 |
| NSC 746087 | 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone | 0.00126165886744895 | 0.43477535 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.00134950525162029 | 0.5099223 |
| NSC 129518 | Cyclopyrethrosin | 0.00134950525162029 | 0.36886176 |
| NSC 301477 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- | 0.00134950525162029 | 0.61915076 |